Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1978 1
1979 1
1981 1
1983 1
1985 2
1986 1
1987 1
1988 3
1989 4
1990 2
1991 6
1992 7
1993 4
1994 3
1995 4
1996 4
1997 2
1998 6
1999 8
2000 17
2001 12
2002 16
2003 30
2004 36
2005 36
2006 41
2007 49
2008 61
2009 61
2010 68
2011 73
2012 110
2013 132
2014 133
2015 198
2016 215
2017 216
2018 232
2019 264
2020 333
2021 228
Text availability
Article attribute
Article type
Publication date

Search Results

2,367 results
Results by year
Filters applied: . Clear all
Page 1
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak.
Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, Zhang Z, You H, Wu M, Zheng Q, Xiong Y, Xiong H, Wang C, Chen C, Xiong F, Zhang Y, Peng Y, Ge S, Zhen B, Yu T, Wang L, Wang H, Liu Y, Chen Y, Mei J, Gao X, Li Z, Gan L, He C, Li Z, Shi Y, Qi Y, Yang J, Tenen DG, Chai L, Mucci LA, Santillana M, Cai H. Dai M, et al. Cancer Discov. 2020 Jun;10(6):783-791. doi: 10.1158/2159-8290.CD-20-0422. Epub 2020 Apr 28. Cancer Discov. 2020. PMID: 32345594 Free PMC article. Clinical Trial.
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ā‰„ 2 HER2-Directed Regimens: Phase III NALA Trial.
Saura C, Oliveira M, Feng YH, Dai MS, Chen SW, Hurvitz SA, Kim SB, Moy B, Delaloge S, Gradishar W, Masuda N, Palacova M, Trudeau ME, Mattson J, Yap YS, Hou MF, De Laurentiis M, Yeh YM, Chang HT, Yau T, Wildiers H, Haley B, Fagnani D, Lu YS, Crown J, Lin J, Takahashi M, Takano T, Yamaguchi M, Fujii T, Yao B, Bebchuk J, Keyvanjah K, Bryce R, Brufsky A; NALA Investigators. Saura C, et al. Among authors: dai ms. J Clin Oncol. 2020 Sep 20;38(27):3138-3149. doi: 10.1200/JCO.20.00147. Epub 2020 Jul 17. J Clin Oncol. 2020. PMID: 32678716 Free PMC article. Clinical Trial.
Telomere-related Markers for Cancer.
Yuan X, Dai M, Xu D. Yuan X, et al. Among authors: dai m. Curr Top Med Chem. 2020;20(6):410-432. doi: 10.2174/1568026620666200106145340. Curr Top Med Chem. 2020. PMID: 31903880 Free PMC article. Review.
Selection and dissemination of antimicrobial resistance in Agri-food production.
Cheng G, Ning J, Ahmed S, Huang J, Ullah R, An B, Hao H, Dai M, Huang L, Wang X, Yuan Z. Cheng G, et al. Among authors: dai m. Antimicrob Resist Infect Control. 2019 Oct 21;8:158. doi: 10.1186/s13756-019-0623-2. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 31649815 Free PMC article. Review.
Association of insulin resistance and Ī²-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study.
Wang T, Lu J, Shi L, Chen G, Xu M, Xu Y, Su Q, Mu Y, Chen L, Hu R, Tang X, Yu X, Li M, Zhao Z, Chen Y, Yan L, Qin G, Wan Q, Dai M, Zhang D, Gao Z, Wang G, Shen F, Luo Z, Qin Y, Chen L, Huo Y, Li Q, Ye Z, Zhang Y, Liu C, Wang Y, Wu S, Yang T, Deng H, Zhao J, Lai S, Bi Y, DeFronzo RA, Wang W, Ning G; China Cardiometabolic Disease and Cancer Cohort Study Group. Wang T, et al. Among authors: dai m. Lancet Diabetes Endocrinol. 2020 Feb;8(2):115-124. doi: 10.1016/S2213-8587(19)30425-5. Epub 2019 Dec 23. Lancet Diabetes Endocrinol. 2020. PMID: 31879247
Thyroid dysfunction may be associated with poor outcomes in patients with COVID-19.
Zhang Y, Lin F, Tu W, Zhang J, Choudhry AA, Ahmed O, Cheng J, Cui Y, Liu B, Dai M, Chen L, Han D, Fan Y, Zeng Y, Li W, Li S, Chen X, Shen M, Pan P; medical team from Xiangya Hospital to support Hubei, China. Zhang Y, et al. Among authors: dai m. Mol Cell Endocrinol. 2021 Feb 5;521:111097. doi: 10.1016/j.mce.2020.111097. Epub 2020 Dec 2. Mol Cell Endocrinol. 2021. PMID: 33278491 Free PMC article.
2,367 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page